167 related articles for article (PubMed ID: 11374657)
1. The hormone continuum: accrual of women's health benefits.
Linn ES; Kaunitz AM; Schnare S; Taylor M
Int J Fertil Womens Med; 2001; 46(2):60-72. PubMed ID: 11374657
[TBL] [Abstract][Full Text] [Related]
2. The impact of hormone replacement therapy on metabolic syndrome components in perimenopausal women.
Korljan B; Bagatin J; Kokić S; Berović Matulić N; Barsić Ostojić S; Deković A
Med Hypotheses; 2010 Jan; 74(1):162-3. PubMed ID: 19665311
[TBL] [Abstract][Full Text] [Related]
3. Consider prescribing OCs for perimenopause use.
Contracept Technol Update; 2000 Mar; 21(3):31-3. PubMed ID: 12349548
[TBL] [Abstract][Full Text] [Related]
4. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
Henderson VW
Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
[TBL] [Abstract][Full Text] [Related]
6. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
7. Women's issues of migraine in tertiary care.
Kelman L
Headache; 2004 Jan; 44(1):2-7. PubMed ID: 14979877
[TBL] [Abstract][Full Text] [Related]
8. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
10. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes.
Bassuk SS; Manson JE
Ann Epidemiol; 2015 Mar; 25(3):193-200. PubMed ID: 25534509
[TBL] [Abstract][Full Text] [Related]
13. Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.
Honebrink A
Expert Opin Emerg Drugs; 2005 Aug; 10(3):619-41. PubMed ID: 16083332
[TBL] [Abstract][Full Text] [Related]
14. [Menopause: where are we three years beyond WHI?].
Reuse C; Fraisse T; Luzuy F; de Ziegler D
Rev Med Suisse; 2006 Feb; 2(53):467, 469-70, 472 passim. PubMed ID: 16533005
[TBL] [Abstract][Full Text] [Related]
15. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
Peeyananjarassri K; Baber R
Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
[TBL] [Abstract][Full Text] [Related]
17. A comparative review of the risks and benefits of hormone replacement therapy regimens.
Warren MP
Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
[TBL] [Abstract][Full Text] [Related]
18. Attitudes towards the menopause and hormone therapy over the turn of the century.
Lindh-Astrand L; Brynhildsen J; Hoffmann M; Liffner S; Hammar M
Maturitas; 2007 Jan; 56(1):12-20. PubMed ID: 16797891
[TBL] [Abstract][Full Text] [Related]
19. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.
Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
Climacteric; 2007 Dec; 10(6):508-26. PubMed ID: 18049944
[TBL] [Abstract][Full Text] [Related]
20. [Phytoestrogens--an alternative to hormonal replacement therapy].
Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
